Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_03912
Species: Homo sapiens
Position : chr2:60494251-60495546
Year: 2020
Title: Therapeutic base editing of human hematopoietic stem cells.
Genome Build: hg38
Enhancer Type: Enhancer
Condition: Disease
Disease Name: sickle cell disease
PMID:  32284612
MONDO: MONDO:0011382
Tissue: blood
Tissue Ontology ID: UBERON:0000178
Cell Source: CD34+ hematopoietic stem and progenitor cells
Cell Type: hematopoietic stem cell
Cell Ontology ID: CL:0000037
Experiment Type: Functional perturbation assay; enhancer editing assay; Disease-variant functional analysis; In vivo functional validation
High Throughput Method: Amplicon deep sequencing; Illumina sequencing
Low Throughput Method: CRISPR base editing; RT-qPCR; HbF measurement; HPLC; sickling assay; In vivo phenotyping
About Target Gene
Target gene : BCL11A
About TF
TF name : GATA1
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
GATA1 C-MYB transcription factor network pid 87
GATA1 Factors involved in megakaryocyte development and platelet production reactome 111
GATA1 IL3 netpath 84
GATA1 Notch-mediated HES/HEY network pid 48
GATA1 p73 transcription factor network pid 80
GATA1 Signaling events mediated by HDAC Class I pid 89
GATA1 Signaling events mediated by HDAC Class II pid 58
Enhancer Associated Network
Overlapping Enhancers (hg38) 3 found
Enhancer ID Position Tissue Cell Disease
E_03913 chr2:60494251-60495546 blood hematopoietic stem cell beta-thalassemia
E_03914 chr2:60494251-60495546 blood hematopoietic stem cell sickle cell disease
E_03915 chr2:60494251-60495546 blood hematopoietic stem cell beta-thalassemia
Expression of Target Genes for the Enhancer